Go Deep
Immuneering Corporation
Immuneering Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,827 | -3.8 | 1.21 | 0.02 | 339.03 |
| Oct 2026 | 21,934 | -3.7 | 1.16 | 0.02 | 324.72 |
| Oct 2026 | 21,766 | -4.0 | 1.24 | 0.02 | 345.66 |
| Oct 2026 | 21,805 | -3.9 | 1.22 | 0.02 | 340.03 |
| Oct 2026 | 21,751 | -3.9 | 1.24 | 0.02 | 347.03 |
| Oct 2026 | 21,698 | -4.0 | 1.26 | 0.02 | 353.67 |
| Oct 2026 | 21,691 | -4.0 | 1.27 | 0.02 | 353.74 |
| Oct 2026 | 21,637 | -4.1 | 1.29 | 0.02 | 359.63 |
Immuneering Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -17,270,427.0 | -13,460,895.0 | -11,580,010.0 | -14,964,875.0 |
| EPS | -0.3 | -0.2 | -0.2 | -0.4 |
Immuneering Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 316,952.0 | — |
| Net Profit | -56,024,898.0 | -61,036,608.0 | -53,471,622.0 | -50,513,568.0 | — |
| EPS | -1.3 | -2.0 | -1.9 | -1.9 | — |
Immuneering Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 231,985,010.0 | 52,714,413.0 | 102,584,538.0 | 122,367,283.0 | — |
| Total Liabilities | 13,501,042.0 | 11,328,187.0 | 12,008,355.0 | 12,517,028.0 | — |
| Total Equity | 218,483,968.0 | 41,386,226.0 | 90,576,183.0 | 109,850,255.0 | — |
Owes vs Owns
Immuneering Corporation owed $0.06 for every $1 it owned in Jun 2026, down from $0.10 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.06× | 0.06× | 0.21× | 0.12× | 0.10× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Immuneering Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 74.5%Fixed assets (tangible) 1.8%Intangible assets 3.0%Long-term investments 19.0%Other assets 1.6%
How it's funded — Dec 2025
Long-term debt 1.5%Payables 0.7%Other liabilities 3.5%Shareholders' equity 94.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 172.8 | 36.1 | 85.7 | 105.5 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 4.3 | 4.8 | 5.4 | 5.8 |
| Intangible assets | 7.0 | 7.0 | 7.1 | 7.1 |
| Long-term investments | 44.2 | 0.0 | 0.0 | 0.0 |
| Other assets | 3.7 | 4.7 | 4.5 | 4.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 0.3 | 0.3 | 0.4 |
| Long-term debt | 3.4 | 3.8 | 4.2 | 4.5 |
| Payables | 1.5 | 2.0 | 2.1 | 3.2 |
| Other liabilities | 8.1 | 5.2 | 5.4 | 4.5 |
| Shareholders' equity | 218.5 | 41.4 | 90.6 | 109.9 |
| Net tangible assets | 211.5 | 34.3 | 83.5 | 102.8 |
Immuneering Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -45,344,595.0 | -54,999,571.0 | -48,968,634.0 | -44,101,265.0 | — |
| Investing Activities | -88,738,247.0 | 26,434,955.0 | 7,296,492.0 | 41,831,002.0 | — |
| Financing Activities | 226,583,147.0 | 5,303,519.0 | 28,441,073.0 | 19,004.0 | — |